751.88Open777.85Pre Close1 Volume1 Open Interest6300.00Strike Price75.19KTurnover0.00%IV0.30%PremiumApr 29, 2025Expiry Date735.08Intrinsic Value100Multiplier0DDays to Expiry16.80Extrinsic Value100Contract SizeEuropeanOptions Type--Delta--Gamma7.56Leverage Ratio--Theta--Rho--Eff Leverage--Vega
S&P 500 Index Stock Discussion
Play by different rules
S&P 500 $S&P 500 Index (.SPX.US)$ gained +0.28%, led by Microsoft $Microsoft (MSFT.US)$ (+0.55%) and Meta $Meta Platforms (META.US)$ (+0.42%), while Tesla $Tesla (TSLA.US)$ (-1.12%) $Alphabet-A (GOOGL.US)$ and Amazon $Amazon (AMZN.US)$ (-0.40%) ...
Heck, last Monday, the day of our marketplace's most recent panicke...
On China side, he said he had no further details and wouldn't confirm if negotiations were even taking place with the country. Is he also calling his own President’s bluff?
$SPDR S&P 500 ETF (SPY.US)$ $S&P 500 Index (.SPX.US)$ $Invesco QQQ Trust (QQQ.US)$ $Strategy (MSTR.US)$ $Super Micro Computer (SMCI.US)$ $Tesla (TSLA.US)$ $NVIDIA (NVDA.US)$ $GameStop (GME.US)$ $Microsoft (MSFT.US)$ $Alphabet-A (GOOGL.US)$ $Meta Platforms (META.US)$ $SPDR Gold ETF (GLD.US)$ $Coca-Cola (KO.US)$ $Nike (NKE.US)$ $PepsiCo (PEP.US)$ $Lululemon Athletica (LULU.US)$
wake me up at 5575
$Pfizer (PFE.US)$'s stock rose Tuesday after the drug manufacturer said it's trending toward the higher end of its 2025 profit projections.
Pfizer also beat analyst expectations for first-quarter earnings as it benefited from cost-saving efforts, although it fell short of Wall Street's revenue estimate, as sales of its COVID-19 medicine Paxlovid plunged by 75% on fading demand.
"Our focus on operational efficiency and financial discipline is driving strong results to our bottom l...
No comment yet